IMMUNOVO.COM

Immunovo

Peptide-based vaccination against VEGF results in efficient antitumor activity. November 18, 2016 / 0 Comments. CCMO approval for Phase I hVEGF26-104 vaccine. April 7, 2014 / 0 Comments. Immunotherapy is breakthrough of the year. February 23, 2014 / 0 Comments. Immunovo’s COO Ilona Enninga PhD. February 7, 2014 / 0 Comments. For more information about our products or our work, contact us! Peptide-based vaccination against VEGF results in efficient antitumor activity. Immunovo’s COO Ilona Enninga PhD.

http://www.immunovo.com/

OVERVIEW OF immunovo.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

10

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR IMMUNOVO.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.2 out of 5 with 9 reviews

5 star

3

4 star

0

3 star

4

2 star

0

1 star

2

Hey there! Start your review of immunovo.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

1.8 seconds

FAVICON PREVIEW

16x16
32x32
64x64
128x128
160x160
192x192
256x256

CONTACTS AT IMMUNOVO.COM

Immunovo

Onderwi●●●●●●●ard 219

Den●●●sch , 5223de

NL

073-●●●●4520

Mi●●●●●●●●●●●●●@WTIc.nl

View this contact

Immunovo

Immunovo

Onderwi●●●●●●●ard 219

Den●●●sch , null, 5223de

NL

073-●●●●4520

Mi●●●●●●●●●●●●●@WTIc.nl

View this contact

null

Role Account, XS4ALL Domain

Post●●●●1848

Amster●●●●●●000 BV , NH, 1112 XH

NL

1.32●●●●7654

1.32●●●●7604

ne●●●●●●●●●●●●●●@xs4all.nl

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2010 March 29
UPDATED: 2014 March 14
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

15

YEARS
6

MONTHS
28

DAYS

NAME SERVERS

1: ns.xs4all.nl
2: ns2.xs4all.nl

REGISTRAR

NETWORK SOLUTIONS, LLC.

WHOIS : whois.networksolutions.com

REFERRED : http://networksolutions.com

CONTENT

PAGES IN
THIS WEBSITE

10

SSL

EXTERNAL LINKS

1

SITE IP

77.74.50.44

LOAD TIME

1.77 sec

SCORE

6.2

PAGE TITLE

Immunovo | immunovo.com Reviews

<META> DESCRIPTION

Peptide-based vaccination against VEGF results in efficient antitumor activity. November 18, 2016 / 0 Comments. CCMO approval for Phase I hVEGF26-104 vaccine. April 7, 2014 / 0 Comments. Immunotherapy is breakthrough of the year. February 23, 2014 / 0 Comments. Immunovo’s COO Ilona Enninga PhD. February 7, 2014 / 0 Comments. For more information about our products or our work, contact us! Peptide-based vaccination against VEGF results in efficient antitumor activity. Immunovo’s COO Ilona Enninga PhD.

<META> KEYWORDS

1 immunovo b v

2 about us

3 product portfolio

4 team

5 news

6 who we are

7 what we do

8 latest news items

9 menu

10 recent news

CONTENT

Page content here

KEYWORDS ON PAGE

immunovo b v,about us,product portfolio,team,news,who we are,what we do,latest news items,menu,recent news,contact info,address,onderwijs boulevard 219,zip code,city,den bosch,phone,e mail,info@immunovo com,disclaimer,immunovo com,back to top

SERVER

Apache/2

POWERED BY

PHP/5.2.8

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Immunovo | immunovo.com Reviews

https://immunovo.com

Peptide-based vaccination against VEGF results in efficient antitumor activity. November 18, 2016 / 0 Comments. CCMO approval for Phase I hVEGF26-104 vaccine. April 7, 2014 / 0 Comments. Immunotherapy is breakthrough of the year. February 23, 2014 / 0 Comments. Immunovo’s COO Ilona Enninga PhD. February 7, 2014 / 0 Comments. For more information about our products or our work, contact us! Peptide-based vaccination against VEGF results in efficient antitumor activity. Immunovo’s COO Ilona Enninga PhD.

INTERNAL PAGES

immunovo.com

1

Immunovo – Product portfolio

http://www.immunovo.com/product-portfolio

Call Us: 31 (0) 73 - 627 4520 - Mail info@immunovo.com. A therapeutic vaccine against the bone remodeling protein sclerostin (SCLER). This protein is thought to interfere with canonical Wnt/&A therapeutic vaccine against the bone remodeling protein sclerostin (SCLER). This protein. Immune recognition and elimination of malignant cells require a series of steps orchestrated by the innate and the adaptive arms of the immune system. The majority of tumors have evolved. Immunovo’s COO Ilona Enninga PhD.

2

Immunovo – Investigational immunotherapies offer bright prospects in advanced melanoma

http://www.immunovo.com/investigational-immunotherapies-offer-bright-prospects-in-advanced-melanoma

Call Us: 31 (0) 73 - 627 4520 - Mail info@immunovo.com. Investigational immunotherapies offer bright prospects in advanced melanoma. Investigational immunotherapies offer bright prospects in advanced melanoma. June 12, 2013. For more information about our products or our work, contact us! CCMO approval for Phase I hVEGF26-104 vaccine. Immunotherapy is breakthrough of the year. Immunovo’s COO Ilona Enninga PhD. Investigational immunotherapies offer bright prospects in advanced melanoma. 31 (0) 73 627 4520.

3

Immunovo – CCMO approval for Phase I hVEGF26-104 vaccine

http://www.immunovo.com/ccmo-approval-for-phase-i-hvegf26-104-vaccine

Call Us: 31 (0) 73 - 627 4520 - Mail info@immunovo.com. CCMO approval for Phase I hVEGF26-104 vaccine. CCMO approval for Phase I hVEGF26-104 vaccine. April 7, 2014. Recently ImmuNovo and VUmc have received CCMO approval for Phase I with hVEGF26-104 vaccine in combination with the RFASE based adjuvant in the Department of Medical Oncology of VUmc Amsterdam headed by Professor Dr Henk Verheul. ImmuNovo’s CEO Joost van Bree PhD: ‘We are delighted to make this important step forward.’. 31 (0) 73 627 4520.

4

Immunovo – Immunovo’s COO Ilona Enninga PhD

http://www.immunovo.com/immunovos-coo-ilona-enninga-phd

Call Us: 31 (0) 73 - 627 4520 - Mail info@immunovo.com. Immunovo’s COO Ilona Enninga PhD. Immunovo’s COO Ilona Enninga PhD. February 7, 2014. Dr Ilona C. Enninga has been Technical Director of NOTOX BV. WIL Research Europe BV) and since 2013 Immunovo’s COO. See Ilona Enninga’s profile page. For more information about our products or our work, contact us! CCMO approval for Phase I hVEGF26-104 vaccine. Immunotherapy is breakthrough of the year. Immunovo’s COO Ilona Enninga PhD. 31 (0) 73 627 4520.

5

Immunovo – Team

http://www.immunovo.com/team

Call Us: 31 (0) 73 - 627 4520 - Mail info@immunovo.com. PhD, Chief Executive Officer. Ron van ‘t Hof. Consultant Chemistry, Manufacturing and Control. PhD, Consultant Non-Clinical Development. Prof Dr. Bob Pinedo MD. PhD, Senior Medical and Scientific Advisor. PhD, Chief Operating Officer. For more information about our products or our work, contact us! CCMO approval for Phase I hVEGF26-104 vaccine. Immunotherapy is breakthrough of the year. Immunovo’s COO Ilona Enninga PhD. 31 (0) 73 627 4520.

UPGRADE TO PREMIUM TO VIEW 5 MORE

TOTAL PAGES IN THIS WEBSITE

10

OTHER SITES

immunovirology.com

HIV-Laboratory of Molecular Immunology

Arroyo de Castro, Carmen. Blanco Miranda, Almudena. Chonco Jiménez, Louis. Clemente Mayoral, Mª Isabel. Correa Rocha, Rafael. De las Cuevas Moreno, Nati. Díaz Muñoz, Laura. Gallego de la Fuente, Jorge. García Alonso, Lola. Garcia Garcia, Mª Isabel. García Merino, Isabel. Garcia Torre , Almudena. Gómez Rico, Coral. Glez-Nicolás Garrido, Mª José. Gonzalo Lázaro, Teresa. Jiménez de Ory, Santiago. Jiménez Fuentes, José Luis. López Fernandez, Luis. Lorente Rodríguez, Raquel. Martínez Colom, Alberto.

immunovis.com

Immunovis

Immunovis è un prodotto in polvere per sospensione orale costituito da estratti vegetali e. Tindalizzato. Secondo la letteratura internazionale, gli ingredienti contenuti in Immunovis svolgono un'azione sull'organismo mirata a migliorare la protezione immunitaria. Secondo la letteratura internazionale, il. Compensa il deficit di secrezione di IgA, il componente più importante del biofilm protettivo intestinale; l’azione probiotica del. Enteropatogeno). L’estratto secco di Echinacea purpurea. Stimola nell...

immunovision.com

Home - ImmunoVision

Protein and Antibody Labeling. ImmunoVision 1820 Ford Ave Springdale, Arkansas 72764. Monday Friday 8:00 am to 4:30 pm Central Phone (479) 751-7005 Fax (479) 751 7002. Site customized by 3c21 Design.

immunovit.ru

Метаболит Плюс (быв. Иммуновит) профессора Родомана В.Е., 47 натуральных компонентов, приобрести в Интернет-магазине :: Главная

Метаболит Лайф 3 Что это? Метаболит Лайф 3 Состав. Применение Метаболит Лайф 3. Метаболит Лайф 3 и Метаболит Плюс - Отзывы. Интервью с автором Иммуновита. Метаболит Плюс - Исследования. Метаболит Лайф 3 FAQ Вопросы. Как приобрести Метаболит Лайф 3. Метаболит Лайф Metabolite Life. Сайт об Иммуновите - уникальном отечественном запатентованном препарате, не имеющем аналогов в мире. Книга профессора Родомана В.Е. - руководство для врачей, имеющее СанЭпидЗаключение Роспотребнадзора. Состоящего из 672 стр.

immunovita.com

Index of /

Apache Server at www.immunovita.com Port 80.

immunovo.com

Immunovo

Peptide-based vaccination against VEGF results in efficient antitumor activity. November 18, 2016 / 0 Comments. CCMO approval for Phase I hVEGF26-104 vaccine. April 7, 2014 / 0 Comments. Immunotherapy is breakthrough of the year. February 23, 2014 / 0 Comments. Immunovo’s COO Ilona Enninga PhD. February 7, 2014 / 0 Comments. For more information about our products or our work, contact us! Peptide-based vaccination against VEGF results in efficient antitumor activity. Immunovo’s COO Ilona Enninga PhD.

immunoway.com

ImmunoWay Biotechnology Company

Cell-Based Colorimetric ELISA Kit. Cell-Based Fluorometric ELISA Kit. HS Sandwich ELISA Kit. Growth Factors and Hormones. Phospho Jak/Stat II Pathway. Phospho Insulin Receptor Pathway. Phospho GPCR Signaling to MAPK/ERK. Phospho Cell Cycle Control/DNA Damage. Phospho Tyrosine Kinase Adaptors. Phospho T-Cell Receptor Signaling. 2012 ImmunoWay Biotechnology Company. Involved in cancer, apoptosis, cell replica watches. Growth, and signal transduction.

immunowayrer.blogspot.com

Immunoway

Lunedì 12 febbraio 2007. Welcome to Immunoway, the web site dedicated to allergy meetings. March, 23-24 2007. Paderno Dugnano, Italy. Paolo Colombo, Palermo. Jonas Lidholm, Upssala. Turin Palace Hotel,. Via Sacchi, 8 Turin, Italy. Per ingrandire l'immagine cliccarci sopra. Immagine del Turin Palace Hotel (palazzo bianco al centro) ripresa dal satellite della Google Earth JR. Language: The official language of the meeting is English. Tel and Fax 39 011/6474729. Sito: www.immunoway.it. March 23, 2007.

immunoweb.com

Immunoweb.com - Ready For Development

Contact Us for Details. If you're interested in this domain, contact us to check availability for ownership, customer use, partnership or other development opportunities. By continuing you agree to our Terms of Use. We respect your privacy and will keep your personal info confidential. Contact us to see if this domain is available with one of our monthly e-Inclusive Web Packages. Looking for another name? Choose Domain Only, Web Packages, or Other Services. 2018 Immunoweb.com Terms of Use.

immunoweb.net

Mijndomein

Dit domein is geregistreerd door een klant van. Spaties en leestekens zijn niet toegestaan in domeinnamen. Domeinnamen mogen alleen bestaan uit letters en cijfers.

immunowell.com

Immunowell | Everyone deserves a fit immune system

Everyone deserves a fit immune system. Origin of the initiative. Your experience contains knowledge. Immunowell Human Science Lab. Pilot Human Science Lab. Broad view on health. Immune Fitness: never ill? What is a Chronic Immune Disorder? Different diseases, 1 mechanism. Immunowell Publication: how fit is your immune system? The Scientific Focus Group of Immunowell published their Position Paper in Frontiers in Immunology. Read more. Developing knowledge via research and stories of experiental experts.